Access to medicine transforms lives.</br>Join us on a mission to reach 8 billion. | Access to Medicine

2026 AMR Benchmark

AMR doesn’t just threaten infection control. It undermines modern medicine.

Learn why AMR matters

2026 AMR Benchmark

Tools to fight AMR exist, but industry-wide action is needed to tilt the battle against superbugs

2026 AMR Benchmark

The Methodology for the 2026 AMR Benchmark

Explore what the Benchmark measures

News

Read the latest at the Foundation

How the Foundation is driving real progress toward global health equity

2026 Index Methodology zeroes in on scalable actions capable of delivering lasting impact for more people

Research hub

Explore the findings from the 2024 Access to Medicine Index

Featured Key findings

Pharma companies are taking steps to address access in low-income countries, but significant gaps remain

19 November 2024

Featured Key findings

Patients in low- and middle-income countries largely left out of clinical trials, limiting access to new treatments

19 November 2024

Events and engagements

Sharing our insights to help drive change

Foundation to host roundtable on generic and biosimilar producers’ potential to improve access to medicine in Africa

Panel discussion

Jayasree K. Iyer to attend JP Morgan 2026 Healthcare Conference in San Francisco

14 January 2026

Steffi Van Uytfanghe to speak at webinar on medical oxygen access barriers in LMICs

21 November 2025

Featured Launch

Foundation to co-host event with Fleming Initiative on AMR

Media coverage

Read more about our coverage in global media

Op-ed: How AI can help bridge healthcare gaps worldwide

17 February 2026

Ozempic generics are coming. But will low-income countries benefit?

27 November 2025